Share Email Print
cover

Proceedings Paper

Raman spectroscopy of human vitreous collagen in diabetic retinopathy
Author(s): Jerry Sebag; Shuming Nie; Karen M. Reiser; Nai-Teng Yu
Format Member Price Non-Member Price
PDF $14.40 $18.00
cover GOOD NEWS! Your organization subscribes to the SPIE Digital Library. You may be able to download this paper for free. Check Access

Paper Abstract

In diabetes nonenzymatic glycation alters collagen throughout the body resulting in the histopathology that underlies diabetic disease in several organs. In the eye such changes in vitreous collagen could contribute to vitreous degeneration and the progression of proliferative diabetic retinopathy. Previous studies have demonstrated early glycation and advanced endproducts in the vitreous of humans with proliferative diabetic retinopathy. Near-infrared Fourier-transform Raman spectroscopy was performed on vitreous obtained at surgery from diabetic patients and from non-diabetic control subjects. The findings were compared to measurements obtained in untreated and glycated (in vitro) rat-tail tendon collagen. The results demonstrated substantial changes in diabetic vitreous collagen resulting from glycation, most likely advanced glycation endproducts. This approach appears to be useful as a means of characterizing the molecular changes induced by diabetes. Furthermore, this technique could be developed as a way of quantifying these changes in vivo in several tissues, so as to gauge the severity of non-enzymatic glycation and monitor the response to therapy.

Paper Details

Date Published: 14 August 1992
PDF: 4 pages
Proc. SPIE 1644, Ophthalmic Technologies II, (14 August 1992); doi: 10.1117/12.137422
Show Author Affiliations
Jerry Sebag, Univ. of Southern California School of Medicine (United States)
Shuming Nie, Univ. of California/Davis (United States)
Karen M. Reiser, Georgia Institute of Technology (United States)
Nai-Teng Yu, Hong Kong Univ. of Science and Technology (Hong Kong China)


Published in SPIE Proceedings Vol. 1644:
Ophthalmic Technologies II
Jean-Marie Parel, Editor(s)

© SPIE. Terms of Use
Back to Top